Literature DB >> 8033754

The dopamine D2 receptor gene: a genetic risk factor in substance abuse.

D E Comings1, D Muhleman, C Ahn, R Gysin, S D Flanagan.   

Abstract

Drug abuse has grown to epidemic proportions. Dopaminergic reward pathways have frequently been implicated in the etiology of drug addiction. To examine the possible role of genetic variants of the dopamine D2 (DRD2) gene in susceptibility to drug abuse we determined the prevalence of the TaqI A1 variant of the DRD2 gene in 200 white patients hospitalized in the Addiction Treatment Unit of a Veterans Administration Hospital. While the prevalence of the D2A1 allele was not significantly increased over controls, it did increase from 21% in subjects with alcohol abuse only to 32% in subjects with alcohol dependence only, consistent with other studies showing an association with the severity of alcoholism. By contrast, of 104 subjects with a discharge diagnosis of drug and alcohol abuse/dependence, 42.3% carried the D2A1 allele versus 29.0% of the 763 white controls (representing all white controls published to date) (P = 0.006). Of those who spent more than $25/week on two or more substances, 56.9% carried the D2A1 allele versus 28.2% of those abusing a single substance (P < 0.0005). Multiple logistic regression analysis showed a highly significant association between multiple substance abuse based on money spent and the presence of the D2A1 allele (P = 0.0003) and age of onset of abuse (P < 0.0001). D2A1 carriers exceeded D2A2A2 subjects for a history of being expelled from school for fighting (P = 0.001), and of those ever jailed for violent crimes, 53.1% carried the D2A1 allele versus 28.8% of those jailed for non-violent crimes (P = 0.011).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033754     DOI: 10.1016/0376-8716(94)90154-6

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  21 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 2.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 3.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

4.  A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence.

Authors:  Fan Wang; Arthur Simen; Albert Arias; Qun-Wei Lu; Huiping Zhang
Journal:  Hum Genet       Date:  2012-12-01       Impact factor: 4.132

5.  Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal:  Med Hypotheses       Date:  2014-02-26       Impact factor: 1.538

6.  Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence.

Authors:  San-Yuan Huang; Wei-Wen Lin; Fang-Jung Wan; Ai-Ju Chang; Huei-Chen Ko; Tso-Jen Wang; Pei-Lin Wu; Ru-Band Lu
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

Review 7.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

8.  Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior.

Authors:  Michela Marinelli; Donald C Cooper; Lorinda K Baker; Francis J White
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

9.  Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics.

Authors:  Alexandra E Shields; Douglas E Levy; David Blumenthal; Douglas Currivan; Mary McGinn-Shapiro; Kevin B Weiss; Recai Yucel; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2008-06       Impact factor: 4.244

Review 10.  Extinction circuits for fear and addiction overlap in prefrontal cortex.

Authors:  Jamie Peters; Peter W Kalivas; Gregory J Quirk
Journal:  Learn Mem       Date:  2009-04-20       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.